These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 36696355)

  • 21. The cost-effectiveness of systematic screening for age-related macular degeneration in South Korea.
    Ra H; Song LD; Choi JA; Jee D
    PLoS One; 2018; 13(10):e0206690. PubMed ID: 30379971
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The long-term outcomes of four alternative treatment strategies for primary open-angle glaucoma.
    van Gestel A; Webers CA; Severens JL; Beckers HJ; Jansonius NM; Hendrikse F; Schouten JS
    Acta Ophthalmol; 2012 Feb; 90(1):20-31. PubMed ID: 22289192
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cost Utility of Schlemm's Canal Microstent Injection With Cataract Surgery for Open-angle Glaucoma in the US Medicare System.
    Atik A; Rhodes LA; Samuels BC; Mennemeyer ST; Girkin CA
    J Glaucoma; 2022 Jun; 31(6):413-422. PubMed ID: 35089891
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Health care cost and benefits of artificial intelligence-assisted population-based glaucoma screening for the elderly in remote areas of China: a cost-offset analysis.
    Xiao X; Xue L; Ye L; Li H; He Y
    BMC Public Health; 2021 Jun; 21(1):1065. PubMed ID: 34088286
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The cost-effectiveness of routine office-based identification and subsequent medical treatment of primary open-angle glaucoma in the United States.
    Rein DB; Wittenborn JS; Lee PP; Wirth KE; Sorensen SW; Hoerger TJ; Saaddine JB
    Ophthalmology; 2009 May; 116(5):823-32. PubMed ID: 19285730
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cost-effectiveness analysis of iStent trabecular micro-bypass stent for patients with open-angle glaucoma in Colombia.
    Ordóñez JE; Ordóñez A; Osorio UM
    Curr Med Res Opin; 2019 Feb; 35(2):329-340. PubMed ID: 30049226
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cost-effectiveness of artificial intelligence screening for diabetic retinopathy in rural China.
    Huang XM; Yang BF; Zheng WL; Liu Q; Xiao F; Ouyang PW; Li MJ; Li XY; Meng J; Zhang TT; Cui YH; Pan HW
    BMC Health Serv Res; 2022 Feb; 22(1):260. PubMed ID: 35216586
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The cost-effectiveness of screening for oral cancer in primary care.
    Speight PM; Palmer S; Moles DR; Downer MC; Smith DH; Henriksson M; Augustovski F
    Health Technol Assess; 2006 Apr; 10(14):1-144, iii-iv. PubMed ID: 16707071
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Selective laser trabeculoplasty versus drops for newly diagnosed ocular hypertension and glaucoma: the LiGHT RCT.
    Gazzard G; Konstantakopoulou E; Garway-Heath D; Garg A; Vickerstaff V; Hunter R; Ambler G; Bunce C; Wormald R; Nathwani N; Barton K; Rubin G; Morris S; Buszewicz M
    Health Technol Assess; 2019 Jun; 23(31):1-102. PubMed ID: 31264958
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Screening strategies for atrial fibrillation: a systematic review and cost-effectiveness analysis.
    Welton NJ; McAleenan A; Thom HH; Davies P; Hollingworth W; Higgins JP; Okoli G; Sterne JA; Feder G; Eaton D; Hingorani A; Fawsitt C; Lobban T; Bryden P; Richards A; Sofat R
    Health Technol Assess; 2017 May; 21(29):1-236. PubMed ID: 28629510
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Integrating opportunistic glaucoma screening into general health examinations in China: A pilot study.
    Zhang S; Sun J; Liu S; Liang Y; Hu Y; Congdon N; Pang CP; Wang H
    Clin Exp Ophthalmol; 2019 Nov; 47(8):1000-1008. PubMed ID: 31152490
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The cost-effectiveness of medication, laser trabeculoplasty, and trabeculectomy for treatment of open-angle glaucoma in South Korea.
    Choi JA; Song LD; Choi S; Park SM; Kwon JW; Jee D
    Medicine (Baltimore); 2019 Jan; 98(2):e14026. PubMed ID: 30633194
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Developing the clinical components of a complex intervention for a glaucoma screening trial: a mixed methods study.
    ; Burr JM; Campbell MK; Campbell SE; Francis JJ; Greene A; Hernández R; Hopkins D; McCann SK; Vale LD
    BMC Med Res Methodol; 2011 Apr; 11():54. PubMed ID: 21510850
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cost-effectiveness of a National Telemedicine Diabetic Retinopathy Screening Program in Singapore.
    Nguyen HV; Tan GS; Tapp RJ; Mital S; Ting DS; Wong HT; Tan CS; Laude A; Tai ES; Tan NC; Finkelstein EA; Wong TY; Lamoureux EL
    Ophthalmology; 2016 Dec; 123(12):2571-2580. PubMed ID: 27726962
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Maximizing cost-effectiveness by adjusting treatment strategy according to glaucoma severity.
    Guedes RAP; Guedes VMP; Gomes CEM; Chaoubah A
    Medicine (Baltimore); 2016 Dec; 95(52):e5745. PubMed ID: 28033286
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cost-Utility Analysis of a Latanoprost Cationic Emulsion (STN1013001) versus Other Latanoprost in the Treatment of Open-Angle Glaucoma or Ocular Hypertension and Concomitant Ocular Surface Disease in Germany.
    Lazzaro C; van Steen C; Billeit S; Frauenknecht H; Kallen C; Pfennigsdorf S; Thelen U; Angelillo L
    Clin Ophthalmol; 2022; 16():323-337. PubMed ID: 35173411
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The cost-effectiveness of one-time opportunistic screening for atrial fibrillation in different age cohorts of inhabitants in Denmark aged 65 years and above: a Markov modelled analysis.
    Sciera LK; Frost L; Dybro L; Poulsen PB
    Eur Heart J Qual Care Clin Outcomes; 2022 Mar; 8(2):177-186. PubMed ID: 33337469
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Surveillance for ocular hypertension: an evidence synthesis and economic evaluation.
    Burr JM; Botello-Pinzon P; Takwoingi Y; Hernández R; Vazquez-Montes M; Elders A; Asaoka R; Banister K; van der Schoot J; Fraser C; King A; Lemij H; Sanders R; Vernon S; Tuulonen A; Kotecha A; Glasziou P; Garway-Heath D; Crabb D; Vale L; Azuara-Blanco A; Perera R; Ryan M; Deeks J; Cook J
    Health Technol Assess; 2012 Jun; 16(29):1-271, iii-iv. PubMed ID: 22687263
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The clinical effectiveness and cost-effectiveness of cardiac resynchronisation (biventricular pacing) for heart failure: systematic review and economic model.
    Fox M; Mealing S; Anderson R; Dean J; Stein K; Price A; Taylor RS
    Health Technol Assess; 2007 Nov; 11(47):iii-iv, ix-248. PubMed ID: 17999842
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cost-effectiveness of targeted screening for the identification of patients with atrial fibrillation: evaluation of a machine learning risk prediction algorithm.
    Hill NR; Sandler B; Mokgokong R; Lister S; Ward T; Boyce R; Farooqui U; Gordon J
    J Med Econ; 2020 Apr; 23(4):386-393. PubMed ID: 31855091
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.